Medical Cannabis for IBS — Switzerland 2026
The endocannabinoid system regulates gut motility and visceral perception. Cannabis can ease IBS symptoms — much cheaper for members.
TL;DR: IBS affects ~10 % of the Swiss population. The gut is rich in CB1/CB2 receptors; cannabinoids modulate motility and visceral hypersensitivity. Wong 2011 (RCT): dronabinol reduced colonic motility in IBS-D. CBD-rich oils empirically effective for pain and anxiety. CannabisClub members: 50 CHF flat instead of 190.
What the studies show
Wong 2011 (RCT, n=75): dronabinol 2.5–5 mg reduced colonic motility in IBS-diarrhoea.
Camilleri 2013: CB1 activation reduces visceral hypersensitivity in human studies.
Cohorts 2020–2024: 70 % of IBS patients on cannabis report pain/cramp reduction and better quality of life.
Preparations & dosing
CBD oil 25–75 mg twice daily as base — well tolerated, no high.
Dronabinol 2.5 mg evenings, titratable for strong cramps.
THC:CBD 1:1 (Sativex-like) for combined pain-anxiety pattern.
Vaporised flower for acute cramp relief, not recommended as maintenance.
Save as a CannabisClub member
Gastroenterology rarely prescribes IBS cannabis. External consult 190 CHF, member 50 CHF flat. Registration free.
FAQ
Does cannabis work in all IBS types?
Best in IBS-D (diarrhoea) and IBS-M (mixed). In IBS-C (constipation) caution — THC can further slow motility.
What does membership save?
50 CHF instead of 190 CHF per consultation. Registration free.
Does insurance cover cannabis in IBS?
Rarely — IBS is not in the standard art. 71a coverage. Usually out of pocket.